vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and FRANKLIN STREET PROPERTIES CORP (FSP). Click either name above to swap in a different company.
FRANKLIN STREET PROPERTIES CORP is the larger business by last-quarter revenue ($26.0M vs $21.2M, roughly 1.2× Autolus Therapeutics plc). FRANKLIN STREET PROPERTIES CORP runs the higher net margin — -28.1% vs -373.3%, a 345.2% gap on every dollar of revenue. FRANKLIN STREET PROPERTIES CORP produced more free cash flow last quarter ($-12.7M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Franklin Street Properties Corp is a Massachusetts-based real estate investment trust (REIT) in the United States. It primarily invests in, owns, and operates high-quality office properties across major U.S. metropolitan markets, serving corporate tenants across various industry segments, and delivers stable long-term returns via rental income and strategic asset management.
AUTL vs FSP — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $26.0M |
| Net Profit | $-79.1M | $-7.3M |
| Gross Margin | — | 59.4% |
| Operating Margin | -337.9% | -27.9% |
| Net Margin | -373.3% | -28.1% |
| Revenue YoY | — | -8.2% |
| Net Profit YoY | 3.6% | 14.1% |
| EPS (diluted) | $-0.30 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $26.0M | ||
| Q3 25 | $21.2M | $27.3M | ||
| Q2 25 | $20.9M | $26.7M | ||
| Q1 25 | $9.0M | $27.1M | ||
| Q4 24 | — | $28.4M | ||
| Q3 24 | $0 | $29.7M | ||
| Q2 24 | $0 | $30.8M | ||
| Q1 24 | $10.1M | $31.2M |
| Q4 25 | — | $-7.3M | ||
| Q3 25 | $-79.1M | $-8.3M | ||
| Q2 25 | $-47.9M | $-7.9M | ||
| Q1 25 | $-70.2M | $-21.4M | ||
| Q4 24 | — | $-8.5M | ||
| Q3 24 | $-82.1M | $-15.6M | ||
| Q2 24 | $-58.3M | $-21.0M | ||
| Q1 24 | $-52.7M | $-7.6M |
| Q4 25 | — | 59.4% | ||
| Q3 25 | — | 60.9% | ||
| Q2 25 | — | 59.9% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 59.7% | ||
| Q3 24 | — | 61.0% | ||
| Q2 24 | — | 64.2% | ||
| Q1 24 | — | 64.7% |
| Q4 25 | — | -27.9% | ||
| Q3 25 | -337.9% | -30.5% | ||
| Q2 25 | -292.6% | -29.2% | ||
| Q1 25 | -726.3% | -78.9% | ||
| Q4 24 | — | -29.9% | ||
| Q3 24 | — | -52.4% | ||
| Q2 24 | — | -68.0% | ||
| Q1 24 | -384.1% | -24.0% |
| Q4 25 | — | -28.1% | ||
| Q3 25 | -373.3% | -30.5% | ||
| Q2 25 | -229.0% | -29.5% | ||
| Q1 25 | -781.1% | -79.1% | ||
| Q4 24 | — | -30.0% | ||
| Q3 24 | — | -52.6% | ||
| Q2 24 | — | -68.2% | ||
| Q1 24 | -522.1% | -24.2% |
| Q4 25 | — | $-0.06 | ||
| Q3 25 | $-0.30 | $-0.08 | ||
| Q2 25 | $-0.18 | $-0.08 | ||
| Q1 25 | $-0.26 | $-0.21 | ||
| Q4 24 | — | $-0.09 | ||
| Q3 24 | $-0.31 | $-0.15 | ||
| Q2 24 | $-0.22 | $-0.20 | ||
| Q1 24 | $-0.24 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $30.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $607.0M |
| Total Assets | $661.9M | $892.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $30.6M | ||
| Q3 25 | $86.1M | $31.4M | ||
| Q2 25 | $123.8M | $29.4M | ||
| Q1 25 | $95.8M | $30.2M | ||
| Q4 24 | — | $41.1M | ||
| Q3 24 | $657.1M | $40.9M | ||
| Q2 24 | $705.9M | $30.2M | ||
| Q1 24 | $758.5M | $34.2M |
| Q4 25 | — | $607.0M | ||
| Q3 25 | $265.5M | $615.3M | ||
| Q2 25 | $346.5M | $624.7M | ||
| Q1 25 | $371.1M | $633.4M | ||
| Q4 24 | — | $655.9M | ||
| Q3 24 | $477.0M | $665.4M | ||
| Q2 24 | $527.8M | $682.1M | ||
| Q1 24 | $582.0M | $703.9M |
| Q4 25 | — | $892.9M | ||
| Q3 25 | $661.9M | $901.0M | ||
| Q2 25 | $721.0M | $903.2M | ||
| Q1 25 | $746.3M | $916.4M | ||
| Q4 24 | — | $946.9M | ||
| Q3 24 | $827.5M | $981.5M | ||
| Q2 24 | $853.6M | $1.0B | ||
| Q1 24 | $901.4M | $1.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $3.8M |
| Free Cash FlowOCF − Capex | $-72.3M | $-12.7M |
| FCF MarginFCF / Revenue | -341.2% | -48.6% |
| Capex IntensityCapex / Revenue | 20.8% | 63.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $-25.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.8M | ||
| Q3 25 | $-67.9M | $8.3M | ||
| Q2 25 | $-72.8M | $-2.9M | ||
| Q1 25 | $-75.6M | $-5.5M | ||
| Q4 24 | — | $9.0M | ||
| Q3 24 | $-76.7M | $14.5M | ||
| Q2 24 | $-51.1M | $-648.0K | ||
| Q1 24 | $-40.5M | $-7.1M |
| Q4 25 | — | $-12.7M | ||
| Q3 25 | $-72.3M | $3.0M | ||
| Q2 25 | $-80.1M | $-5.7M | ||
| Q1 25 | $-83.8M | $-9.9M | ||
| Q4 24 | — | $-16.2M | ||
| Q3 24 | $-86.3M | $8.6M | ||
| Q2 24 | $-51.9M | $-5.1M | ||
| Q1 24 | $-41.0M | $-15.8M |
| Q4 25 | — | -48.6% | ||
| Q3 25 | -341.2% | 11.0% | ||
| Q2 25 | -382.6% | -21.5% | ||
| Q1 25 | -933.1% | -36.7% | ||
| Q4 24 | — | -57.2% | ||
| Q3 24 | — | 29.1% | ||
| Q2 24 | — | -16.7% | ||
| Q1 24 | -406.8% | -50.8% |
| Q4 25 | — | 63.0% | ||
| Q3 25 | 20.8% | 19.4% | ||
| Q2 25 | 34.8% | 10.7% | ||
| Q1 25 | 91.8% | 16.4% | ||
| Q4 24 | — | 88.9% | ||
| Q3 24 | — | 19.6% | ||
| Q2 24 | — | 14.6% | ||
| Q1 24 | 5.3% | 28.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
